期刊论文详细信息
BMC Public Health
Proactive tobacco treatment for low income smokers: study protocol of a randomized controlled trial
Anne M Joseph4  John A Nyman2  Janet L Thomas4  Barbara Clothier1  David Nelson4  Diana J Burgess4  Michelle van Ryn3  Steven S Fu4 
[1] VA HSR&D Center for Chronic Disease Outcomes Research, Minneapolis VA Health Care System, 1 Veterans Drive (152), Minneapolis, MN 55417, USA;Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN, USA;Mayo Clinic, Division of Health Care Policy & Research, Rochester, MN, USA;Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA
关键词: Minority health;    Low-income population;    Health care disparities;    Smoking cessation;   
Others  :  1131584
DOI  :  10.1186/1471-2458-14-337
 received in 2014-03-27, accepted in 2014-04-02,  发布年份 2014
PDF
【 摘 要 】

Background

There is a high prevalence of smoking and high burden of tobacco-related diseases among low-income populations. Effective, evidenced-based smoking cessation treatments are available, but low-income smokers are less likely than higher-income smokers to use these treatments, especially the most comprehensive forms that include a combination of pharmacotherapy and intensive behavioral counseling.

Methods/Design

The primary objectives of this randomized controlled trial are to compare the effects of a proactive tobacco treatment intervention compared to usual care on population-level smoking abstinence rates and tobacco treatment utilization rates among a diverse population of low-income smokers, and to determine the cost-effectiveness of proactive tobacco treatment intervention. The proactive care intervention systematically offers low-income smokers free and easy access to evidence-based treatments and has two primary components: (1) proactive outreach to current smokers in the form of mailed invitation materials and telephone calls containing targeted health messages, and (2) facilitated access to free, comprehensive, evidence-based tobacco cessation treatments in the form of NRT and intensive, telephone-based behavioral counseling. The study aims to include a population-based sample (N = 2500) of adult smokers enrolled in the Minnesota Health Care Programs (MHCP), a state-funded health insurance plan for low-income persons. Baseline data is obtained from MHCP administrative databases and a participant survey that is conducted prior to randomization. Outcome data is collected from a follow-up survey conducted 12 months after randomization and MHCP administrative data. The primary outcome is six-month prolonged smoking abstinence at one year and is assessed at the population level. All randomized individuals are asked to complete the follow-up survey, regardless of whether they participated in tobacco treatment. Data analysis of the primary aims will follow intent-to-treat methodology.

Discussion

There is a critical need to increase access to effective tobacco dependence treatments. This randomized trial evaluates the effects of proactive outreach coupled with free NRT and telephone counseling on the population impact of tobacco dependence treatment. If proven to be effective and cost-effective, national dissemination of proactive treatment approaches would reduce tobacco-related morbidity, mortality, and health care costs for low income Americans.

Clinical trials registration

ClinicalTrials.gov: NCT01123967

【 授权许可】

   
2014 Fu et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150302233351456.pdf 336KB PDF download
Figure 1. 60KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Agaku IT, King BA, Dube SR: Current cigarette smoking among adults- United States, 2005–2012. MMWR Morb Mortal Wkly Rep 2014, 63:29-34.
  • [2]Schiller JS, Lucas JW, Ward BW, Peregoy JA: Summary health statistics for U.S. adults: national health interview survey, 2010. Vital Health Stat 10 2012, 252:1-207.
  • [3]Fu SS, Sherman SE, Yano EM, van Ryn M, Lanto AB, Joseph AM: Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promot 2005, 20:108-116.
  • [4]Fu SS, Kodl MM, Joseph AM, Hatsukami DK, Johnson EO, Breslau N, Wu B, Bierut L: Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev 2008, 17:1640-1647.
  • [5]Thorndike AN, Biener L, Rigotti NA: Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health 2003, 92:437-442.
  • [6]Cokkinides VE, Ward E, Jemal A, Thun MJ: Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med 2005, 28:119-122.
  • [7]Levinson AH, Perez-Stable EJ, Espinoza P, Flores ET, Byers TE: Latinos report less use of pharmaceutical aids when trying to quit smoking. Am J Prev Med 2004, 26:105-111.
  • [8]Burns ME, Fiore MC: Under-use of tobacco dependence treatment among Wisconsin’s fee-for-service Medicaid recipients. WMJ 2001, 100:54-58.
  • [9]Rumberger JS, Hollenbeak CS, Kline D: Potential costs and benefits of smoking cessation in the united states. 2010. [http://www.lung.org/stop-smoking/tobacco-control-advocacy/reports-resources/cessation-economic-benefits/reports/SmokingCessationTheEconomicBenefits.pdf webcite]
  • [10]Centers for Disease Control and Prevention: State Medicaid coverage for tobacco-dependence treatments---United States, 1998 and 2000. MMWR Morb Mortal Wkly Rep 2001, 50:979-982.
  • [11]Centers for Disease Control and Prevention: State medicaid coverage for tobacco-dependence treatments --- United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:1340-1343.
  • [12]McMenamin SB, Halpin HA, Ibrahim JK, Orleans CT: Physician and enrollee knowledge of Medicaid coverage for tobacco dependence treatments. Am J Prev Med 2004, 26:99-104.
  • [13]Murphy JM, Shelley D, Repetto PM, Cummings KM, Mahoney MC: Impact of economic policies on reducing tobacco use among Medicaid clients in New York. Prev Med 2003, 37:68-70.
  • [14]Komaromy M, Lurie N, Bindman AB: California physicians’ willingness to care for the poor. West J Med 1995, 162:127-132.
  • [15]Browning KK, Ferketich AK, Salsberry PJ, Wewers ME: Socioeconomic disparity in provider-delivered assistance to quit smoking. Nicotine Tob Res 2008, 10:55-61.
  • [16]McMenamin SB, Halpin HA, Bellows NM: Knowledge of Medicaid coverage and effectiveness of smoking treatments. Am J Prev Med 2006, 31:369-374.
  • [17]Solberg LI, Davidson G, Alesci NL, Boyle RG, Magnan S: Physician smoking-cessation actions: are they dependent on insurance coverage or on patients? Am J Prev Med 2002, 23:160-165.
  • [18]Blumenthal DS: Barriers to the provision of smoking cessation services reported by clinicians in underserved communities. J Am Board Fam Med 2007, 20:272-279.
  • [19]Frazier LM, Molgaard CA, Fredrickson DD, Early JL, Schukman JS, Dismuke SE: Barriers to smoking cessation initiatives for Medicaid clients in managed care. Subst Use Misuse 2001, 36:1875-1899.
  • [20]Abrams DB, Orleans CT, Niaura RS, Goldstein MG, Prochaska JO: Integrating individual and public health perspectives for tobacco treatment under managed health care: a combined stepped-care and matching model. Ann Behav Med 1996, 18:290-304.
  • [21]Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE: Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003, 5:13-25.
  • [22]Bandura A: Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
  • [23]Prochaska JO, DiClemente CC: Stages and process of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983, 51:390-395.
  • [24]Clark R, Anderson NB, Clark VR, Williams DR: Racism as a stressor for African Americans. A biopsychosocial model. Am Psychol 1999, 54:805-816.
  • [25]DiClemente CC: Motivational Interviewing and the stages of change. In Motivational Interviewing: Preparing People to Change Adictive Behavior. Edited by Miller WR, Rollnick S. New York: Guilford Press; 1991:191-202.
  • [26]Biener L, Abrams DB: The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol 1991, 10:360-365.
  • [27]Fu SS, Burgess DJ, van Ryn M, Hatsukami DK, Solomon J, Joseph AM: Views on smoking cessation methods in ethnic minority communities: a qualitative investigation. Prev Med 2007, 44:235-240.
  • [28]Zhu SH, Anderson CM, Tedeschi GJ, Rosbrook GJ, Johnson CE, Byrd M, Gutierrez-Terrell E: Evidence of real-world effectiveness of a telephone quitline for smokers.comment]. N Engl J Med 2002, 347:1087-1093.
  • [29]Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME: Treating Tobacco use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: USDHHS, Public Health Service; 2008.
  • [30]Fiore MC, Jaen CR: A clinical blueprint to accelerate the elimination of tobacco use. JAMA 2008, 299:2083-2085.
  • [31]Gibson PJ, Koepsell TD, Diehr P, Hale C: Increasing response rates for mailed surveys of Medicaid clients and other low-income populations. Am J Epidemiol 1999, 149:1057-1062.
  • [32]Edlund C: An effective methodology for surveying a Medicaid population: the 1996 Oregon Health Plan client satisfaction survey. J Ambul Care Manage 1997, 20:37-45.
  • [33]Gallagher PM, Fowler FJ, Stringfellow VL: Notes from the Field: experiments in influencing response rates from medicaid enrollees. In Proceedings of the 55th Annual Conference of the American Association for Public Opinion Research.. Portland, Oregon: American Statistical Association; 2000.
  • [34]Dillman DA: Mail and Internet Surveys: The Tailored Design Method. New York, NY: John Wiley & Sons Inc.; 2000.
  • [35]Fowler FJ Jr, Gallagher PM, Stringfellow VL, Zaslavsky AM, Thompson JW, Cleary PD: Using telephone interviews to reduce nonresponse bias to mail surveys of health plan members. Med Care 2002, 40:190-200.
  • [36]SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002, 4:149-159.
  • [37]California tobacco surveys 2010. [http://libraries.ucsd.edu/locations/sshl/data-gov-info-gis/ssds/guides/tobacco-surveys.html webcite]
  • [38]Behavioral risk factor surveillance system questionnaire 2010. [http://www.cdc.gov/brfss/questionnaires.htm webcite]
  • [39]Etter JF, le Houezec J, Perneger TV: A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology 2003, 28:359-370.
  • [40]PROMIS Cooperative Group: Unpublished Manual for the Patient-Reported Outcomes Measurement System (PROMIS) Version 1.1. 2009. [http://www.Nihpromis.Org webcite]
  • [41]Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005, 43:203-220.
  • [42]Davis RM: Healthcare report cards and tobacco measures. Tob Control 1997, 6(Suppl 1):S70-S77.
  • [43]Johnson RL, Saha S, Arbelaez JJ, Beach MC, Cooper LA: Racial and ethnic differences in patient perceptions of bias and cultural competence in health care. J Gen Intern Med 2004, 19:101-110.
  • [44]Ware JE Jr, Snyder MK, Wright WR, Davies AR: Defining and measuring patient satisfaction with medical care. Eval Program Plann 1983, 6:247-263.
  • [45]Baldwin AS, Rothman AJ, Hertel AW, Linde JA, Jeffery RW, Finch EA, Lando HA: Specifying the determinants of the initiation and maintenance of behavior change: an examination of self-efficacy, satisfaction, and smoking cessation. Health Psychol 2006, 25:626-634.
  • [46]Etter JF, Perneger TV: Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clin Pharmacol Ther 2001, 69:175-183.
  • [47]Kessler RC, Mickelson KD, Williams DR: The prevalence, distribution, and mental health correlates of perceived discrimination in the United States. J Health Soc Behav 1999, 40:208-230.
  • [48]Wahl OF: Mental health consumers’ experience of stigma. Schizophr Bull 1999, 2(5):467-478.
  • [49]Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Heyman RB, Jaen CR, Kottke TE, Lando HA, Mecklenburg RE, Mullen PD, Nett LM, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME: Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Service. Public Health Service; 2000.
  • [50]Nelson DB, Partin MR, Fu SS, Joseph AM, An LC: Why assigning ongoing tobacco use is not necessarily a conservative approach to handling missing tobacco cessation outcomes. Nicotine Tob Res 2009, 11:77-83.
  • [51]Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-effectiveness in Heath and Medical Care. New York: Oxford University Press; 1997.
  文献评价指标  
  下载次数:45次 浏览次数:4次